skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Necroptosis in the Pathophysiology of Disease

The American journal of pathology, 2020-02, Vol.190 (2), p.272-285 [Peer Reviewed Journal]

2020 American Society for Investigative Pathology ;Copyright © 2020 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved. ;2020 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved. 2020 American Society for Investigative Pathology ;ISSN: 0002-9440 ;EISSN: 1525-2191 ;DOI: 10.1016/j.ajpath.2019.10.012 ;PMID: 31783008

Full text available

Citations Cited by
  • Title:
    Necroptosis in the Pathophysiology of Disease
  • Author: Khoury, Mitri K. ; Gupta, Kartik ; Franco, Sarah R. ; Liu, Bo
  • Subjects: Animals ; Chronic Disease - epidemiology ; Chronic Disease - therapy ; Disease - etiology ; Humans ; Inflammation - physiopathology ; Necroptosis
  • Is Part Of: The American journal of pathology, 2020-02, Vol.190 (2), p.272-285
  • Description: Over the past 15 years, elegant studies have demonstrated that in certain conditions, programed cell death resembles necrosis and depends on a unique molecular pathway with no overlap with apoptosis. This form of regulated necrosis is represented by necroptosis, in which the receptor-interacting protein kinase-3 and its substrate mixed-lineage kinase domain-like protein play a crucial role. With the development of knockout mouse models and molecular inhibitors unique to necroptotic proteins, this cell death has been found to occur in virtually all tissues and diseases evaluated. There are different immunologic consequences depending on whether cells die through apoptosis or necroptosis. Therefore, distinguishing between these two forms of cell death may be crucial during pathologic evaluations. In this review, we provide an understanding of necroptotic cell-death and highlight diseases in which necroptosis has been found to play a role. We also discuss the inhibitors of necroptosis and the ways these inhibitors have been used in preclinical models of diseases. These two discussions offer an understanding of the role of necroptosis in diseases and will foster efforts to pharmacologically target this unique yet pervasive form of programed cell death in the clinic.
  • Publisher: United States: Elsevier Inc
  • Language: English
  • Identifier: ISSN: 0002-9440
    EISSN: 1525-2191
    DOI: 10.1016/j.ajpath.2019.10.012
    PMID: 31783008
  • Source: Geneva Foundation Free Medical Journals at publisher websites
    MEDLINE
    PubMed Central
Back to results list
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait